Hoth Therapeutics and Algorithm Sciences Execute Letter of Intent to Merge

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced it has signed a Letter of Intent to merge...

Related Keywords

Mike Tilton ,Robb Knie ,Astra Zeneca ,Anthony Zook ,Hoth Therapeutics Inc ,Lr Advisors ,Nasdaq ,Algorithm Sciences Inc ,Exchange Commission ,Chief Executive Officer ,Pulmonary Arterial Hypertension ,Hoth Therapeutics ,Algorithm Sciences ,David Cavalier ,Investigational New Drug ,Securities Act ,Proposed Transactions ,Private Securities Litigation Reform Act ,Annual Report ,Nc ,